DEF 14A: OneMedNet Corporation Announces 2024 Annual Meeting of Stockholders
Proxy Statement
OneMedNet Corporation will hold its 2024 Annual Meeting of Stockholders virtually on December 19, 2024, to elect directors and ratify the appointment of its independent auditor.
Summary
- OneMedNet Corporation will hold its 2024 Annual Meeting of Stockholders on December 19, 2024, at 11:00 a.m.
- Central Time, via live audio webcast.
- Stockholders of record as of October 31, 2024, are entitled to vote on the election of three Class I directors, the ratification of WithumSmith+Brown, PC as the independent registered public accounting firm for the year ending December 31, 2024, and any other business that may properly come before the meeting.
- The Board of Directors recommends voting for the election of the nominated Class I directors and for the ratification of WithumSmith+Brown, PC.
- The company has retained Laurel Hill Advisory Group, LLC to assist in the solicitation of proxies, with an expected payment of $7,500 plus expenses.
- As of the record date, October 31, 2024, there were 27,987,427 shares of common stock issued and outstanding.
Sentiment
Score: 6
Explanation: The document is primarily informational, outlining the details of the upcoming annual meeting and standard corporate governance matters. The sentiment is neutral, with some slight negatives due to the past issues with accounting firms and reliance on related party transactions.
Positives
- The Board is recommending well-qualified candidates for election as Class I directors.
- The Board is recommending the ratification of WithumSmith+Brown, PC as the independent registered public accounting firm, indicating confidence in their services.
- The company is providing stockholders with multiple ways to vote, including online, by mail, and electronically during the Annual Meeting.
Negatives
- The company previously dismissed Marcum LLP and terminated the engagement of BF Borgers CPA PC as their independent registered public accounting firm.
- BF Borgers was permanently barred from appearing or practicing before the SEC as an accountant.
Risks
- Failure to ratify the appointment of WithumSmith+Brown, PC could lead the Audit Committee to reconsider the appointment, potentially causing disruption.
- The company's reliance on related-party loans and convertible notes could pose risks if these parties were to demand repayment or conversion at unfavorable terms.
- The company's past issues with its independent registered public accounting firms could raise concerns about the reliability of its financial reporting.
Future Outlook
The proxy statement outlines the matters to be voted on at the upcoming Annual Meeting and provides information to stockholders to make informed decisions. The company does not provide specific forward-looking financial guidance in this document.
Management Comments
- Dr. Jeffrey Yu, MD, Chairman of the Board of Directors, cordially invites stockholders to attend the 2024 Annual Meeting.
- The Board of Directors believes that submitting the appointment of Withum to stockholders for ratification is good corporate governance.
Industry Context
The announcement of the Annual Meeting is a standard corporate governance practice. The election of directors and ratification of the auditor are routine matters for publicly traded companies. The virtual format of the meeting reflects a growing trend in corporate governance.
Comparison to Industry Standards
- Holding an annual meeting to elect directors and ratify the appointment of an independent auditor is standard practice for publicly traded companies, such as OneMedNet.
- Companies like McKesson and Optum, where Aaron Green previously held leadership positions, are examples of large healthcare technology companies with established corporate governance practices.
- The use of a virtual meeting format is becoming increasingly common, aligning with practices adopted by companies like Xponential Fitness (NYSE: XPOF), where Jair Clarke serves as a board member.
- The director compensation policy, including annual grants of common stock, is a typical method used by public companies to compensate their board members.
- The presence of an Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, each comprised of independent directors, is consistent with best practices in corporate governance.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Paul Casey | Aaron Green | March 2024 | Retirement of Paul Casey |
| Chief Financial Officer | Lisa Embree | Robert Golden (Interim) | August 2024 | Resignation of Lisa Embree |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Adoption of Clawback Policy | The Board of Directors adopted a compensation clawback policy requiring the company to clawback erroneously awarded incentive compensation received by current and former executive officers during the three fiscal years that precede the date the company is required to prepare an accounting restatement due to material noncompliance with a financial reporting requirement. | November 6, 2024 | Strengthens accountability and aligns executive compensation with financial reporting integrity. |
| Revised Director Compensation Policy | The Board adopted a revised director compensation policy providing for the annual automatic grant of 45,000 shares of common stock to each director for each full year of service. | April 2024 | Provides a standardized compensation structure for directors. |
Legal Proceedings
- The SEC entered an order instituting settled administrative and cease-and-desist proceedings against Borgers and its sole audit partner, Benjamin F. Borgers, permanently barring Mr. Borgers and Borgers from appearing or practicing before the SEC as an accountant.
Related Party Transactions
- The company issued PIPE Notes and Warrants to related party investors, including Mr. Green, Dr. Yu, and Dr. Kosasa.
- The company issued Convertible Promissory Notes and Warrants to related party investors.
- The company entered into shareholder loans with related party investors, including Dr. Yu and Dr. Kosasa.
- The company assumed Data Knights liabilities, which included existing loan extensions to related parties.
Stakeholder Impact
- Stockholders have the opportunity to vote on key corporate governance matters, including the election of directors and the ratification of the independent auditor.
- The outcome of the votes can impact the direction and oversight of the company.
- The disclosure of related-party transactions provides transparency to stakeholders regarding potential conflicts of interest.
Next Steps
- Stockholders should review the proxy materials and vote on the proposals.
- The company will hold the Annual Meeting on December 19, 2024.
- The company will announce preliminary voting results at the Annual Meeting and publish final results in a Current Report on Form 8-K.
Key Dates
| Date | Description |
|---|---|
| February 8, 2021 | Date of the Companys inception. |
| April 25, 2022 | Date of the Merger Agreement. |
| January 1, 2022 | Date from which related person transactions are described. |
| December 31, 2023 | Fiscal year end for which financial statements are included in the Annual Report on Form 10-K/A. |
| December 29, 2023 | Date the Audit Committee dismissed Marcum LLP. |
| May 3, 2024 | Date the SEC entered an order against BF Borgers CPA PC. |
| May 6, 2024 | Date the Audit Committee terminated the engagement of Borgers. |
| June 3, 2024 | Date Withum has served as the independent registered public accounting firm. |
| November 6, 2024 | Date the Board of Directors adopted a compensation clawback policy. |
| November 7, 2024 | Date of the Notice of Annual Meeting of Stockholders. |
| October 31, 2024 | Record date for determining stockholders eligible to vote at the Annual Meeting. |
| December 19, 2024 | Date of the Annual Meeting of Stockholders. |
| July 11, 2025 | Deadline for stockholder proposals to be included in the 2025 proxy statement. |
| August 21, 2025 | Earliest date for receipt of stockholder proposals for the 2025 Annual Meeting. |
| September 20, 2025 | Latest date for receipt of stockholder proposals for the 2025 Annual Meeting. |
| October 20, 2025 | Deadline for stockholders to provide notice of intent to solicit proxies in support of director nominees other than the company's nominees. |
| December 19, 2025 | Anniversary date of the 2024 Annual Meeting. |
| 2027 | Year the Class I directors terms expire. |
Keywords
Annual Meeting, Proxy Statement, Directors, Stockholders, OneMedNet, WithumSmith+Brown, Audit Committee, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.